Versant Capital Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.99K Hold
293
– – ﹤0.01% 2489
2026
Q2
$2.77K Hold
293
– – ﹤0.01% 2522
2026
Q1
$2.68K Buy
+293
New +$2.46K ﹤0.01% 2515

Other funds holding BVS

Versant Capital Management's BVS Position: Q3 2026 in Review

Versant Capital Management held its Bioventus (BVS) position steady in Q3 2026 at 293 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2489.

Versant Capital Management first reported a position in BVS in Q1 2026 and has held it in 3 quarters since. 170 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • Versant Capital Management held 293 shares of Bioventus worth $3.99K as of Q3 2026.
  • Versant Capital Management left its Bioventus share count unchanged in Q3 2026.
  • Bioventus made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2489 holding.
  • Versant Capital Management first reported a position in Bioventus in Q1 2026 and has held it in 3 quarters since.
  • 170 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.